Physician profile
Peter E Kagan
NPI 1932281219
$10,125.49
in general payments reported to CMS, 2019-2025
25 companies · $2,654 in 2025
The $2,654 reported for 2025 was more than what 75% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $212 · 2021: $1,234 · 2022: $291 · 2023: $3,883 · 2024: $1,598 · 2025: $2,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,872 · Travel and Lodging: $2,763 · Education: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,871.70 |
| Travel and Lodging | $2,762.86 |
| Education | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,659.38 | 2023 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $2,081.25 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Silk Road Medical, INC. | $1,195.78 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $1,067.88 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Cook Medical LLC | $471.35 | 2021-2025 | Zenith Spiral-Z, Zilver Ptx, Zilver Vena |
| Penumbra, INC. | $440.35 | 2025 | Indigo System, Ruby Coil |
| Boston Scientific Corporation | $168.11 | 2019-2025 | Enhance Transcarotid Peripheral Access Kit, Embold Fibered |
| Inari Medical, INC. | $154.15 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $137.92 | 2025 | Flowtriever |
| Cvrx, INC. | $131.80 | 2025 | Barostim Neo System |
| Organogenesis INC. | $112.30 | 2019 | |
| Janssen Pharmaceuticals, INC | $66.23 | 2023 | Xarelto |
| Lemaitre Vascular, INC. | $63.82 | 2022-2024 | Pruitt F3 Carotid Shunt |
| Sirtex Medical INC | $61.37 | 2025 | Lava Les (Liquid Embolic System) |
| Thrombolex, INC. | $58.54 | 2024 | Bashir Endovascular Catheter |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $52.60 | 2019-2020 | |
| Kerecis Limited | $44.95 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbvie INC. | $34.01 | 2022 | |
| Imperative Care, INC | $25.00 | 2025 | Symphony Catheter |
| Edwards Lifesciences Corporation | $24.12 | 2019 | |
| Integra Lifesciences Corporation | $20.96 | 2021 | |
| Davol INC. | $20.07 | 2023 | Phasix Mesh |
| Angiodynamics, INC. | $13.87 | 2019 | |
| Cagent Vascular INC | $10.00 | 2025 | Serrantor |
| Cashflow Solutions, LLC | $9.68 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.